Teriparatide acetate hydrate is used to treat osteoporosis in postmenopausal women and men at high risk of fractures. It stimulates new bone formation by mimicking parathyroid hormone activity. Also used in patients with glucocorticoid-induced osteoporosis. It is grouped under the following drug class(es): Hormones and Peptides. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Teriparatide acetate, Parathyroid Hormone (Human, 1-34), Parathar and Parathar acetate. Its PubChem CID is 118984441.
Teriparatide acetate hydrate
| CAS No | 99294-94-7 |
|---|---|
| Molecular Formula | C183H297N55O54S2 |
| Molecular Weight | 4196 g/mol |
| Synonyms | acetic acid;(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(1S)-1-carboxy-2-phenylethyl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Teriparatide acetate hydrate is used to treat osteoporosis in postmenopausal women and men at high risk of fractures. It stimulates new bone formation by mimicking parathyroid hormone activity.
The listed CAS number is 99294-94-7.
The listed molecular formula is C183H297N55O54S2.
The listed molecular weight is 4196 g/mol.
The source lists Teriparatide acetate, Parathyroid Hormone (Human, 1-34), Parathar and Parathar acetate.
Its therapeutic use is listed as anti-osteoporosis agents.